EDT vs. SVA, MDNA, ONC, HLS, TH, CRDL, CWEB, MBX, and HBP
Should you be buying Spectral Medical stock or one of its competitors? The main competitors of Spectral Medical include Sernova (SVA), Medicenna Therapeutics (MDNA), Oncolytics Biotech (ONC), HLS Therapeutics (HLS), Theratechnologies (TH), Cardiol Therapeutics (CRDL), Charlotte's Web (CWEB), Microbix Biosystems (MBX), and Helix BioPharma (HBP). These companies are all part of the "medical" sector.
Sernova (TSE:SVA) and Spectral Medical (TSE:EDT) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, institutional ownership, earnings, media sentiment, valuation, community ranking, risk and analyst recommendations.
Sernova has a beta of 1.6, indicating that its share price is 60% more volatile than the S&P 500. Comparatively, Spectral Medical has a beta of 0.94, indicating that its share price is 6% less volatile than the S&P 500.
Spectral Medical received 123 more outperform votes than Sernova when rated by MarketBeat users. However, 88.89% of users gave Sernova an outperform vote while only 65.17% of users gave Spectral Medical an outperform vote.
In the previous week, Spectral Medical had 2 more articles in the media than Sernova. MarketBeat recorded 3 mentions for Spectral Medical and 1 mentions for Sernova. Spectral Medical's average media sentiment score of 0.84 beat Sernova's score of -0.28 indicating that Sernova is being referred to more favorably in the media.
0.1% of Sernova shares are held by institutional investors. Comparatively, 13.2% of Spectral Medical shares are held by institutional investors. 14.5% of Sernova shares are held by company insiders. Comparatively, 20.5% of Spectral Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Spectral Medical's return on equity of -183.58% beat Sernova's return on equity.
Sernova currently has a consensus target price of C$1.50, indicating a potential upside of 252.94%. Given Spectral Medical's higher possible upside, research analysts clearly believe Sernova is more favorable than Spectral Medical.
Spectral Medical has higher revenue and earnings than Sernova. Spectral Medical is trading at a lower price-to-earnings ratio than Sernova, indicating that it is currently the more affordable of the two stocks.
Summary
Sernova and Spectral Medical tied by winning 7 of the 14 factors compared between the two stocks.
Get Spectral Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for EDT and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding EDT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Spectral Medical Competitors List
Related Companies and Tools
